Saint-Louis Hospital
Paris, 75010, France
NCT Number: NCT02325297
After the death of a patient in the hyper-technical context of intensive care, his relatives are particularly vulnerable and often exhibit symptoms of anxiety, depression, post traumatic stress and complicated grief. The first results of a qualitative study Famiréa current (CAESAR) support the idea that the bereaved relatives suffer from persistent misunderstandings and a feeling of abandonment of the resuscitation team. Many families suggest the need for contact with the team after the patient's death. The letter of condolence received by some families allowed them to feel recognized in their pain resuscitation teams. This has led us to ask the question of post-death monitoring and interest to send to bereaved relatives a letter of condolence, as recommended by the American consensus conference in 2004 on good palliative care. This strategy would allow the recognition of both close to the pain but also the strong bond that united the resuscitation team. The hypothesis of the study is that the post-death followed in the form of a letter of condolence sent by the intensive care physician who was in charge of the patient, could reduce the risk of having symptoms of anxiety / depression and post-traumatic stress and reduce the rate of complicated grief.
Famirea 22 is randomized clinical trial aimin to compare two bereaved groups: one group who did not receive a letter of condolence and a group that received a letter of condolence 15 days after the death.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75010, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month
Time frame: 1 month
a questionnaire describing ICU end-of-life practices and satisfaction with the patient's care, communication, and symptom management during the dying process.
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Assistance Publique - Hôpitaux de Paris
Other
Acronym: Famirea 22
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05462938
Adverse Event, Behavior
Ioannina, Epirus, Greece
View Trial DetailsNCT07499609
Aortic Coarctation, Cardiac Surgery
Montpellier, France
View Trial DetailsNCT02996721
Brain Diseases, Cardiovascular Diseases
Murray, Utah, United States
View Trial DetailsNCT06665919
Adverse Cardiac Events, Arterial Occlusive Diseases
Tbilisi, Georgia
View Trial Details